{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Topical+Solution&page=2", "query": { "intervention": "Vehicle Topical Solution", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Topical+Solution&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T23:30:34.918Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04268069", "title": "Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "PL9643 Ophthalmic Solution", "type": "DRUG" }, { "name": "Placebo Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ORA, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2020-02-14", "completion_date": "2020-10-05", "has_results": false, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 4, "location_summary": "Andover, Massachusetts • Raynham, Massachusetts • Shelby, North Carolina + 1 more", "locations": [ { "city": "Andover", "state": "Massachusetts" }, { "city": "Raynham", "state": "Massachusetts" }, { "city": "Shelby", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04268069" }, { "nct_id": "NCT02405039", "title": "Study of EBI-005 in Dry Eye Disease (DED)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "EBI-005", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eleven Biotherapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 188, "start_date": "2015-04", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2015-06-04", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Newport Beach, California • Hamden, Connecticut + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Newport Beach", "state": "California" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "New Albany", "state": "Indiana" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02405039" }, { "nct_id": "NCT01977781", "title": "Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ocular GVHD" ], "interventions": [ { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Methylprednisolone Sodium Succinate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts Eye and Ear Infirmary", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2013-12", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01977781" }, { "nct_id": "NCT04097730", "title": "Steroids and Cross-linking for Ulcer Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Keratitis Bacterial" ], "interventions": [ { "name": "Moxifloxacin Ophthalmic", "type": "DRUG" }, { "name": "Difluprednate Ophthalmic", "type": "DRUG" }, { "name": "Riboflavin Ophthalmic", "type": "DRUG" }, { "name": "Topical Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Thomas M. Lietman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2020-09-24", "completion_date": "2024-09-18", "has_results": false, "last_update_posted_date": "2025-02-03", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 2, "location_summary": "San Francisco, California • Miami, Florida", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04097730" }, { "nct_id": "NCT02503137", "title": "A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Androgenetic Alopecia" ], "interventions": [ { "name": "Topical SM04554 solution", "type": "DRUG" }, { "name": "Topical Vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biosplice Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 49, "start_date": "2015-08", "completion_date": "2016-04", "has_results": false, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 5, "location_summary": "Clinton Township, Michigan • Cleveland, Ohio • College Station, Texas + 2 more", "locations": [ { "city": "Clinton Township", "state": "Michigan" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "College Station", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02503137" }, { "nct_id": "NCT01933464", "title": "An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "Cromolyn Sodium", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2013-08", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2019-08-07", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01933464" }, { "nct_id": "NCT03464292", "title": "Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia", "Pain" ], "interventions": [ { "name": "Capsaicin Patch 8% or 0.1% Capsaicin Cream", "type": "DRUG" }, { "name": "Vehicle Patch", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 55, "start_date": "2018-07-05", "completion_date": "2023-12-08", "has_results": false, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03464292" }, { "nct_id": "NCT01682811", "title": "Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neurofibromatoses" ], "interventions": [ { "name": "Part 1 Levulan injection", "type": "DRUG" }, { "name": "Part 1 Levulan surface application", "type": "DRUG" }, { "name": "Part 1 Levulan surface application twice", "type": "DRUG" }, { "name": "Part 1 Levulan surface application twice with microneedling", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2", "type": "DRUG" }, { "name": "Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harry T Whelan, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 20, "start_date": "2012-03-12", "completion_date": "2016-07-07", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01682811" }, { "nct_id": "NCT03079973", "title": "Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nail Psoriasis" ], "interventions": [ { "name": "P-3073 (calcipotriene 0.005%)", "type": "DRUG" }, { "name": "Vehicle of P-3073", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Polichem S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2017-05-15", "completion_date": "2018-07", "has_results": false, "last_update_posted_date": "2018-01-10", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "North Hollywood", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03079973" }, { "nct_id": "NCT05896670", "title": "Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "licaminlimab", "type": "DRUG" }, { "name": "vehicle of OCS-02", "type": "OTHER" }, { "name": "Artificial tears", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Oculis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 122, "start_date": "2023-11-29", "completion_date": "2024-03-27", "has_results": false, "last_update_posted_date": "2025-07-02", "last_synced_at": "2026-09-26T23:30:34.918Z", "location_count": 5, "location_summary": "Newport Beach, California • Colorado Springs, Colorado • Shelby, North Carolina + 2 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Shelby", "state": "North Carolina" }, { "city": "Erie", "state": "Pennsylvania" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05896670" } ] }